Novelion Therapeutics Inc (NVLN) – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: September 2020
- Report Code: MLPH3606FSA
Novelion Therapeutics Inc (NVLN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Novelion Therapeutics Inc (Novelion), formerly QLT Inc, is a biopharmaceutical company that focuses on the development and commercialization of products and solutions for the treatment of people living with rare diseases. The company has two marketed products – Lomitapide, a small molecule microsomal triglyceride transfer protein inhibitor which is marketed under the brand name JUXTAPID in the US for treating homozygous familial hypercholesterolemia (HoFH) in adult patients; and Metreleptin, a recombinant analog of human leptin which is marketed under the brand name MYALEPT in the US for treating congenital or acquired generalized lipodystrophy (GL) patients. The company operates along with its subsidiaries across North America, South America, Europe and Asia. Novelion is headquartered in Vancouver, British Columbia, Canada.
Scope
• Detailed information on Novelion Therapeutics Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Novelion Therapeutics Inc in the form of a SWOT analysis
• An in-depth view of the business model of Novelion Therapeutics Inc including a breakdown and examination of key business segments
• News about Novelion Therapeutics Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Novelion Therapeutics Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Novelion Therapeutics Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Novelion Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Sanofi
Eli Lilly and Co
Amgen Inc
RegenxBio Inc
Alnylam Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
NeuroBo Pharmaceuticals Inc
The Medicines Co
Akcea Therapeutics Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.